Head-to-head · WeighScore
AM Rx vs Nirwana Health
The verdict
Nirwana Health takes it — 66.4/100 to 49.6/100.
Nirwana Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nirwana Health (nirwanahealth.com) is a telehealth service offering compounded GLP-1 weight loss plus hair, sexual-wellness, and longevity care through licensed providers.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | AM Rx | Nirwana Health |
|---|---|---|
| WeighScore | 49.6/100 | 66.4/100 |
| Grade | C | C |
| Scorecard rank | #491 | #192 |
| Semaglutide | $151/mo (quarterly plan, plus a separate fee, compounded) | $149/mo (compounded) |
| Tirzepatide | Not disclosed | $229/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #491 · C
Strengths
- Insurance coordination for brand-name GLP-1s — as low as $25/mo
- All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
- HSA and FSA accepted
- Video visits available with providers averaging 10+ years' experience
- Compounded semaglutide from $151/mo on the quarterly plan
Where it loses points
- Active FTC/DOJ lawsuit over deceptive billing and subscription practices
- Novo Nordisk false-advertising lawsuit (Aug 2025)
- Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
- Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #192 · C
Strengths
- Offers compounded semaglutide and tirzepatide as both weekly injections and oral tablets
- Transparent, published pricing with month-to-month, quarterly, and 6-month plans and no membership fee
- Multi-month plans cut the per-month cost sharply (semaglutide as low as $99/mo, tirzepatide as low as $133/mo)
- Advertises a $50-off code (LOOSE50) and covers weight loss plus hair, sexual-wellness, and longevity care
- Also lists a retatrutide option and custom dosing plans for higher needs
Where it loses points
- Prescribing medical group and compounding pharmacy are not named on the site
- States of operation are not published; confirm eligibility during intake
- Says it is 'LegitScript certified' but no verifiable seal is shown, so the claim is unconfirmed
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.